ZA787353B - Pharmaceutical formulations - Google Patents

Pharmaceutical formulations

Info

Publication number
ZA787353B
ZA787353B ZA787353A ZA787353A ZA787353B ZA 787353 B ZA787353 B ZA 787353B ZA 787353 A ZA787353 A ZA 787353A ZA 787353 A ZA787353 A ZA 787353A ZA 787353 B ZA787353 B ZA 787353B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical formulations
formulations
prostacyclin
preparation
amino acid
Prior art date
Application number
ZA787353A
Other languages
English (en)
Inventor
P Marsden
I Watts
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of ZA787353B publication Critical patent/ZA787353B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA787353A 1978-05-17 1978-12-28 Pharmaceutical formulations ZA787353B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2017578 1978-05-17

Publications (1)

Publication Number Publication Date
ZA787353B true ZA787353B (en) 1980-08-27

Family

ID=10141640

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA787353A ZA787353B (en) 1978-05-17 1978-12-28 Pharmaceutical formulations

Country Status (28)

Country Link
US (1) US4335139A (sv)
EP (1) EP0005768B1 (sv)
JP (1) JPS54163809A (sv)
KR (1) KR830000527B1 (sv)
AT (2) AT365926B (sv)
AU (1) AU525695B2 (sv)
BE (1) BE876296A (sv)
CA (1) CA1141661A (sv)
CH (1) CH641044A5 (sv)
CS (1) CS214798B2 (sv)
DE (2) DE2966046D1 (sv)
DK (1) DK156004C (sv)
ES (1) ES480597A1 (sv)
FI (1) FI68359C (sv)
FR (1) FR2425856A1 (sv)
GR (1) GR68452B (sv)
HU (1) HU182746B (sv)
IL (1) IL57298A (sv)
IT (1) IT1116840B (sv)
LU (1) LU81272A1 (sv)
MC (1) MC1265A1 (sv)
NL (1) NL7903871A (sv)
NZ (1) NZ190462A (sv)
PH (1) PH15850A (sv)
PL (1) PL134004B1 (sv)
SE (1) SE450930B (sv)
SU (1) SU978715A3 (sv)
ZA (1) ZA787353B (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3010002A1 (de) * 1980-03-15 1981-10-01 Hoechst Ag, 6000 Frankfurt Prostaglandine enthaltende pharmazeutische zubereitung
GB8814438D0 (en) * 1988-06-17 1988-07-20 Wellcome Found Compounds for use in medicine
KR0158870B1 (ko) * 1988-06-17 1998-12-01 마틴 에이. 로쓰블랫 폐순환 승압의 치료, 예방 또는 진단용 조성물
JP3421330B2 (ja) * 2000-11-02 2003-06-30 持田製薬株式会社 ビダラビン注射用乾燥製剤
EP1238670A1 (en) * 2001-03-07 2002-09-11 Bruce Daniels Composition and method for treating and preventing cardiovascular disease and hypertension.
US7491263B2 (en) 2004-04-05 2009-02-17 Technology Innovation, Llc Storage assembly
DE602006005423D1 (de) * 2005-06-29 2009-04-16 Verisfield Uk Ltd Pharmazeutische Zusammensetzungen von Risperidon in wässriger Lösung
US8318802B2 (en) 2006-02-03 2012-11-27 Actelion Pharmaceuticals Ltd. Epoprostenol formulation and method of making thereof
CN103181893A (zh) 2007-09-07 2013-07-03 联合治疗公司 针对革兰氏阴性细菌具有选择性杀菌活性的缓冲液及其使用方法
HU231031B1 (hu) 2016-03-23 2019-12-30 CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. Megnövelt stabilitású epoprostenol nátrium és eljárás előállítására
DE202024100435U1 (de) 2023-02-14 2024-02-22 Tomasz Dąbrowski Zaunfeld zum Aufbau einer Reitbande

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4036954A (en) 1973-11-02 1977-07-19 Yamanouchi Pharmaceutical Co., Ltd. Stable prostaglandin E group-containing formulation
GB1504437A (en) 1974-03-08 1978-03-22 Dunlop Ltd Rubberplastics composites
DE2515001C2 (de) * 1975-04-04 1986-10-02 Schering AG, 1000 Berlin und 4709 Bergkamen Prostaglandin enthaltende gefriergetrocknete Pulver
US3997587A (en) 1975-06-26 1976-12-14 Syntex (U.S.A.) Inc. D1- and 8R-9-fluoro-prostadienoic acid derivatives
US4005133A (en) 1975-10-14 1977-01-25 The Upjohn Company PGF2.sub.α, L-Arginine salt
FR2351112A1 (fr) * 1975-10-21 1977-12-09 Wellcome Found Derive de prostaglandine et medicament contenant ce derive
US4062964A (en) 1975-12-03 1977-12-13 Ciba-Geigy Corporation Antifertility-combinations
GB1583961A (en) * 1976-05-11 1981-02-04 Wellcome Found Prostacyclin and derivatives thereof
JPS542335A (en) * 1977-05-20 1979-01-09 Wellcome Found Medical composition

Also Published As

Publication number Publication date
DK201879A (da) 1979-11-18
CA1141661A (en) 1983-02-22
FR2425856A1 (fr) 1979-12-14
CH641044A5 (de) 1984-02-15
ATE4411T1 (de) 1983-08-15
KR830000527B1 (ko) 1983-03-12
EP0005768B1 (en) 1983-08-10
AU525695B2 (en) 1982-11-25
DE2920020A1 (de) 1979-11-29
US4335139A (en) 1982-06-15
SU978715A3 (ru) 1982-11-30
JPS54163809A (en) 1979-12-26
LU81272A1 (fr) 1979-12-07
CS214798B2 (en) 1982-05-28
PL215627A1 (sv) 1981-08-07
FI68359C (fi) 1985-09-10
DE2920020C2 (sv) 1988-09-01
BE876296A (fr) 1979-11-16
ES480597A1 (es) 1980-08-16
GR68452B (sv) 1981-12-30
DE2966046D1 (en) 1983-09-15
SE7904284L (sv) 1979-11-18
JPS6358810B2 (sv) 1988-11-17
HU182746B (en) 1984-03-28
NL7903871A (nl) 1979-11-20
IT7949064A0 (it) 1979-05-16
DK156004C (da) 1989-11-06
PL134004B1 (en) 1985-07-31
IL57298A0 (en) 1979-09-30
ATA363479A (de) 1981-07-15
PH15850A (en) 1983-04-13
IL57298A (en) 1983-09-30
MC1265A1 (fr) 1980-03-28
FR2425856B1 (sv) 1982-06-25
AT365926B (de) 1982-02-25
SE450930B (sv) 1987-08-17
AU4704279A (en) 1979-11-22
NZ190462A (en) 1982-05-31
FI791565A (fi) 1979-11-18
IT1116840B (it) 1986-02-10
FI68359B (fi) 1985-05-31
DK156004B (da) 1989-06-12
EP0005768A1 (en) 1979-12-12

Similar Documents

Publication Publication Date Title
PT81839B (pt) Processo de preparacao de formulacoes com propulsores de aerosol a base de clorofluorocarbono contendo medicamento
ZA907492B (en) Stabilized aqueous formulations of small peptides
IT8722481A0 (it) Polipeptidi immunologicamente attivi con una tossicita' alterata utili per la preparazione di un vaccino antipertosse.
FR2425856B1 (sv)
DE2963446D1 (en) New lactyl tetrapeptide, processes for preparation thereof and pharmaceutical compositions containing it
NO883261D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat
ES8703742A1 (es) Procedimiento para preparar un agente acuoso esteril de ac- cion retardada y prolongada,de un peptido o de una proteina
ES2019634B3 (es) Terapia con clorfeniramina.
EG14440A (en) Preparation of an optically active benzamide the optically active benzamide so obtained and pharmaceutical compositions containing it
JPS523023A (en) Preparation of amino acid ester of organopolysiloxane
UA42741C2 (uk) Пептид маститної вакцини (варіанти), пептид складного антигенного представлення (варіанти), фармацевтична композиція (варіанти)
GB2021581A (en) Stabilisation of PGl2 derivatives
AU560165B2 (en) Chromophoric peptides
IL56726A0 (en) Substituted imidazolidinyl-3-cephem-4-carboxylic acids,processes for preparing the same and pharmaceutical or veterinary formulations containing the same
IT8723035A0 (it) Procedimento per la preparazione di n acilaniline.
IT8820888A0 (it) Peptidi di sintesi immunologicamente attivi per lapreparazione di vaccini antimalarici.
GB2162746A (en) Antiacidotic medicinal agent
PT76773B (en) Process for the preparation of an aqueous pharmaceutical composition with salbutamol base
TH4273EX (th) สารผสมที่ใช้เป็นสารพ่นละอองละเอียดต่อต้านการขับเหงื่อ
NO911988L (no) Stabiliserte vandige formuleringer av smaa peptider.
IT7921319A0 (it) Procedimento per la preparazione di clorozocitina e relative formulazioni farmaceutiche.